Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 2

3(42.9%)

N/A

2(28.6%)

Phase 1

1(14.3%)

Phase 3

1(14.3%)

7Total

Phase 2(3)

N/A(2)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07460960Phase 2Recruiting

TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

Role: lead

NCT07399860Phase 2Recruiting

Botulinum Toxin A Before Hemorrhoidectomy to Prevent Postoperative Pain

Role: lead

NCT07422246Not ApplicableNot Yet Recruiting

Prognosis and Diagnosis of Acute Gastrointestinal Dysfunction in Cardiac Surgery Patients

Role: collaborator

NCT06869863Phase 1Recruiting

Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediReg®

Role: lead

NCT04403243Phase 2Completed

COLchicine Versus Ruxolitinib and Secukinumab in Open-label Prospective Randomized Trial in Patients With COVID-19

Role: lead

NCT03726905Not ApplicableCompleted

Complex Exercises of the Respiratory Muscles Plus Aerobic Training vs. Aerobic Training in Patients With СHF

Role: lead

NCT04424134Phase 3Unknown

BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization

Role: lead

All 7 trials loaded